Log In


Reset Password
Linda A. Johnson

Simpler, one-dose treatment to prevent malaria relapse OK’d

U.S. regulators Friday approved a simpler, one-dose treatment to prevent relapses of malaria. Standard treatment now takes two weeks and studies show many patients don’t finish ta...

U.S. hospitals grapple with prolonged injected opioid shortage

TRENTON, N.J. – There is another opioid crisis happening in the U.S., and it has nothing to do with the overdose epidemic: Hospitals are frequently running out of widely used injected painki...

FDA OKs first drug made to reduce excessive sweating

U.S. regulators recently approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause people anxiety and affect their social lives. ...

FDA approves 1st nonopioid drug to ease withdrawal symptoms

TRENTON, N.J. – Federal regulators on Wednesday approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids. The U.S. Food and Drug Administration ex...

U.S. approves 1st drug developed to prevent chronic migraines

TRENTON, N.J. – U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration’s action clears the monthly shot Aimovig (...

Americans filling far fewer opioid prescriptions

TRENTON, N.J. – The number of prescriptions for opioid painkillers filled in the U.S. fell dramatically last year, showing their biggest drop in 25 years and continuing a decline amid increa...

Hospital groups creating company to make cheap generic drugs

TRENTON, N.J. – Several major not-for-profit hospital groups are trying their own solution to drug shortages and high prices: creating a company to make cheaper generic drugs. The...

U.S. OKs 1st drug aimed at women with inherited breast cancer

U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. The Food and Drug Administration on Friday approved Ast...

IV bag shortage has hospitals scrambling to treat flu

TRENTON, N.J. – An ongoing shortage of fluids used to deliver medicine and treat dehydrated patients has hospital workers scrambling in the midst of a nasty flu season and supplies from fact...

Startup wants to bring back Vioxx for hemophilia joint pain

TRENTON, N.J. – Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so. Merck & Co. voluntarily pulled the blockbuster d...

FDA OKs new therapy for some hemophilia patients

TRENTON, N.J – U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia. The Food and Drug Admi...

FDA approves better vaccine against painful shingles virus

U.S. regulators have approved a new, more effective vaccine to prevent painful shingles, which is caused by the chickenpox virus. Drugmaker GlaxoSmithKline said the Food and Drug ...